Cardiositol®

Product description

Dietary supplement containing myo-inositol and D-chiro-inositol, developed to support cardiometabolic health by improving metabolic balance and contributing to cardiovascular protection. Its innovative formulation targets key mechanisms involved in metabolic disorders, supporting insulin sensitivity, lipid metabolism and cardiac health. Scientific evidence from in-vitro, in-vivo and clinical studies highlights its potential role in preventing metabolic alterations and supporting cardiovascular wellbeing.

More products from Lo.Li. Pharma International Srl.

Inofolic® Line

For the management of PCOS and fertility issues. Efficacy of the product line is supported by 60+ international clinical trials in more than 5000 patients. Many published studies demonstrate efficacy in improving metabolic and hormonal imbalance, as well as signs and symptoms of PCOS. It has also been s...

More info

Aleract® Line

Food supplements for pregnancy, for the management of the risk of miscarriage and preterm birth.Four clinical trials demonstrate safety and efficacy of the original formulation with two of the studies demonstrating efficacy in preventing preterm birth, one highlighting its ability to reduce subchorionic he...

More info

Tiroxil® Line

Food supplements for the management of subclinical thyroid disorders. Nine clinical studies demonstrate, among other results, TSH reductions and autoimmunity control in patients with subclinical hypothyroidism after 6 months of treatment using the 4.0 formulation. One clinical trial demonstrates efficac...

More info

Biguanelle® Line

A solution for vaginal infections. Six clinical trials demonstrate the solution's efficacy in clearing bacterial vaginosis, candidiasis, and HPV infections. Two trials prove equivalent efficacy to antibiotics. One systematic review confirms positive results. The pessaries and gel are each supported by a...

More info

Delphys® Line

Food supplements for uterine fibroids management. Clinical efficacy is supported by six clinical trials, which demonstrate a statistically significant reduction in fibroid volume and related symptoms, with a relevant improvement in quality of life. Two clinical trials are ongoing. For Delphys Plus...

More info

Pervistop®

The food supplement for the management of persistent HPV infections. One clinical trial demonstrated a clearance of HPV in 85% of patients after 3 months of administration. One case report and one in-vitro study further support safety and efficacy, while there are two ongoing clinical trials.

More info

View all our products (15)